Doxil
Drug timelines are a Plus or Pro feature.
91 regulatory and trial events tracked for Doxil, covering 2006-09-26 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer [Phase 2]